Disease Detail

ID DOID:120
Name female reproductive organ cancer
Definition A reproductive organ cancer that is manifested in the female genitals. This includes organs such as the ovaries, fallopian tubes, uterus, cervix, vagina and vulva.
Source DiseaseOntology.org
Alt Ids DOID:1244 DOID:1281
Path disease disease of cellular proliferation cancer organ system cancer reproductive organ cancer female reproductive organ cancer

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Molecular Profile Therapy Indication/Tumor Type Response Type Profile Response Detail
Unknown unknown Motolimod + Pegylated liposomal-doxorubicin female reproductive organ cancer no benefit detail...
Unknown unknown Durvalumab + Olaparib female reproductive organ cancer not applicable detail...
Unknown unknown Cediranib + Durvalumab female reproductive organ cancer not applicable detail...
Unknown unknown Lurbinectedin female reproductive organ cancer not applicable detail...
Unknown unknown Pamiparib female reproductive organ cancer not applicable detail...
Clinical Trial Phase Therapies Title Recruitment Status
NCT00800345 Phase I Pazopanib + Topotecan Phase I Trial of Oral Metronomic Topotecan and Oral Pazopanib to Treat Recurrent/Persistent Gynecologic Tumors Completed
NCT01831089 Phase I Bevacizumab + Lurbinectedin + Paclitaxel Lurbinectedin + Paclitaxel Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors Completed
NCT03073525 Phase II Atezolizumab + FANG vaccine Trial of Atezolizumab and Vigil for Advanced Gynecological Cancers (A Companion Study to CL-PTL-119) Active, not recruiting
NCT03277482 Phase I Durvalumab + Tremelimumab Durvalumab Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer Recruiting